Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
ERCC5 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Skin and Connective Tissue Disorders Panel PreventionGenetics United States | 125 | 69 |
|
Progeroid syndromes and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 21 | 21 |
|
Progeroid syndromes and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 21 | 21 |
|
Progeroid syndromes and related disorders NGS panel HNL Genomics Connective Tissue Gene Tests United States | 21 | 21 |
|
Xeroderma pigmentosum Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 9 | 9 |
|
Xeroderma pigmentosum NGS panel HNL Genomics Connective Tissue Gene Tests United States | 9 | 9 |
|
Xeroderma pigmentosum Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 9 | 9 |
|
PreventionGenetics United States | 11 | 9 |
|
Xeroderma Pigmentosum via the ERCC5 Gene PreventionGenetics United States | 1 | 1 |
|
Cataract panel. NGS panel of 69 genes. Genologica Medica Spain | 146 | 69 |
|
Arthrogryposis panel. NGS panel of 69 genes. Genologica Medica Spain | 135 | 69 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.